HomeRNAM • NASDAQ
add
Avidity Biosciences Inc
Previous close
$72.80
Day range
$72.75 - $73.04
Year range
$72.75 - $73.04
Market cap
11.29B USD
Avg Volume
2.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 860.00K | -71.07% |
Operating expense | 88.74M | 213.16% |
Net income | — | — |
Net profit margin | -27.57K | -701.56% |
Earnings per share | -1.59 | -98.75% |
EBITDA | -252.98M | -110.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.70B | 13.01% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.69B | — |
Shares outstanding | 155.15M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -34.63% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | -169.77M | -69.99% |
Cash from investing | 207.22M | 422.91% |
Cash from financing | — | — |
Net change in cash | 32.36M | 121.53% |
Free cash flow | — | — |
About
CEO
Founded
2012
Website
Employees
511
